Ticker Scorecard - CARA Basics Company: Cara Therapeutics, Inc. IPO Date: January 31, 2014 Sector: Healthcare Industry: Biotech Market Cap: $25.43M Activated in VL: True Average Daily Range Avg Daily Range: $0.33 | 3.05% Avg Daily Range (30 D): $0.14 | 7.81% Avg Daily Range (90 D): $0.08 | 6.30% Institutional Daily Volume Avg Daily Volume: .06M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .08M Trade Size Avg Trade Size (Sh.): 12 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 1,391 Avg Inst. Trade: $1.42M Avg Inst. Trade (30 D): $1.21M Avg Inst. Trade (90 D): $1.21M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.42M Avg Closing Trade (30 D): $1.21M Avg Closing Trade (90 D): $1.21M Avg Closing Volume: 8.36K     News Jun 13, 2024 @ 4:21 PM These Cara Therapeutics Analysts Are No Longer Bul... Source: Priya Nigam Jun 13, 2024 @ 12:01 PM Analyst Ratings For Cara Therapeutics Source: Benzinga Insights Jun 12, 2024 @ 8:01 PM Cara Therapeutics Announces Outcome of Part A of K... Source: Cara Therapeutics, Inc. May 14, 2024 @ 4:01 PM In-Depth Examination Of 5 Analyst Recommendations ... Source: Benzinga Insights May 13, 2024 @ 9:10 PM Cara Therapeutics (CARA) Reports Q1 Loss, Misses R... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.75 $-.23 $-.37 Diluted EPS $-1.75 $-.23 $-.37 Revenue $ 8.69M $ 2.56M $ .99M Gross Profit $ $ $ Net Income / Loss $ -95.53M $ -12.48M $ -20.02M Operating Income / Loss $ -85.57M $ -5.99M $ -17.31M Cost of Revenue $ $ $ Net Cash Flow $ -26.22M $ -12.18M $ 2.24M PE Ratio     Splits Dec 31, 2024:   12:1 Jan 16, 2014:   5:2